Publication | Closed Access

Systemic transplantation of allogenic fetal membrane-derived mesenchymal stem cells suppresses Th1 and Th17 T cell responses in experimental autoimmune myocarditis

Regenerative MedicineCell TherapyTransplantationAutoimmune DiseaseMedicineT-regulatory CellStem Cell TransplantationImmunologyExperimental Autoimmune MyocarditisAutoimmunitySystemic TransplantationStem-cell TherapyCell TransplantationMesenchymal Stem CellImmunotherapyStem CellsCell Biology